/Investor DB

Sonder Capital — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

SquareMindsquaremind.cominApr 2026 · $18M

SquareMind develops Swan, an automated robot for full-body dermoscopy that maps the skin and pairs the scans with AI to support change detection.

AI & Machine LearningHealthtechMedical DevicesRoboticsParis, FR

Ali Khachlouf(CEO)inTanguy Serrat(CTO)in

Co-investorsCalm/Storm VCEntrepreneur FirstTeampact.venturesBpifrance

Vitestrovitestro.cominSeries A · Mar 2026 · $70M

Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.

HealthtechMedical DevicesRoboticsNetherlands, NL

Toon Overbeeke(Co-founder & CEO)inBrian Joseph(Co-founder)in

Co-investorsNYBC VenturesIntervestInvest-NLMayo Clinic Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

XCath

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.